Morphophysiopathologic studies on the biology of myocardium in acquired valvulopathies

D Laky1, V Cândea, G Butur

  • 1V. Babeş Institute, Bucureşti.

Insights

Valvulopathy causes progressive myocardial lesions through hemodynamic and hypoxic damage, leading to cell death. Researchers identified edema, fibrosis, and rare ventricular natriuretic granules during ultrastructural analysis.

Area of Science:

  • Cardiovascular Pathology
  • Cellular Biology
  • Histopathology

Background:

  • Valvular heart disease can lead to significant myocardial damage.
  • Hemodynamic and hypoxic factors play a crucial role in the progression of cardiac lesions.
  • Understanding the cellular mechanisms of myocardial injury is essential for therapeutic development.

Purpose of the Study:

  • To investigate the histological, histoenzymological, and ultrastructural changes in myocardial tissue affected by valvulopathies.
  • To elucidate the pathogenic pathways involved in lesion development and progression.
  • To identify specific cellular markers and alterations associated with valvulopathy-induced myocardial damage.

Main Methods:

  • Tissue sampling from patients undergoing open-heart surgery for valvulopathy under extracorporeal circulation.
  • Comprehensive histological, histoenzymological, and ultrastructural examination of myocardial samples.
  • Analysis of cellular and interstitial alterations, including edema, fibrosis, and mitochondrial damage.

Main Results:

  • Identified progressive cardiomyocitary and interstitial lesions driven by hemodynamic and hypoxic stress.
  • Observed chronic perivascular and interstitial edema with impaired lymph drainage.
  • Documented hyalinization, sclerosis, interstitial fibrosis, and cellular damage, including mitochondrial and sarcoplasmic reticulum alterations.
  • Detected lysosomal activation leading to cytolytic foci and the presence of ventricular natriuretic granules.

Conclusions:

  • Valvulopathy induces complex myocardial lesions characterized by edema, fibrosis, and cellular degeneration due to hemodynamic and hypoxic insults.
  • The study highlights the sequential progression of myocardial damage, culminating in cell death and the release of specific granules.
  • Ultrastructural analysis revealed previously underreported features, such as ventricular natriuretic granules, offering new insights into myocardial pathology.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...